Sec. 6. Vaccine safety public awareness campaign
334 words·~2 min read·
/bill/116/s/4262/is/section-6A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The Secretary, acting through the Director of the Centers for Disease Control and Prevention and in coordination with the Office of Minority Health, and, as appropriate, the relevant Offices of Minority Health in the Department of Health and Human Services, the National Institute of Minority Health and Health Disparities, and the Indian Health Service, shall establish grant funding opportunities for eligible entities to disseminate COVID–19 vaccination information. To be eligible to receive a grant under this section, an entity shall be a State, local, Tribal, or territorial health department, an urban Indian organization, a nonprofit community-based organization, or a nonprofit faith-based organization.
Entities receiving a grant under this section shall use such grant funds to— increase awareness to the benefit of receiving a COVID–19 vaccine, and include information on where the vaccine can be obtained; and create and disseminate culturally and linguistically appropriate messaging. The Secretary shall have discretion to award additional grant funding under this section to broaden the grant recipient's vaccine public safety awareness campaign to include routine immunizations and general influenza vaccine messaging.
In awarding grants under this section, the Secretary shall give priority to eligible entities in either urban or rural communities (or a combination of urban and rural communities) that serve vulnerable populations, including ethnic minority populations, which may include low-income, uninsured, and medically underserved individuals or populations with historically low rates of receiving vaccines. The Secretary shall awards the grants under this section not later than 60 days after the date on the earlier of the date on which the Food and Drug Administration licenses a COVID–19 vaccine under section 351 of the Public Health Service Act ( 42 U.S.C. 262 ) or the date on which a manufacturer begins to distribute a COVID–19 vaccine to public or private entities pursuant to an emergency use authorization under section 564 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360bbb–3 ).
There is authorized to be appropriated to carry out this section $5,000,000 for fiscal year 2020.
Connectionstraces to 1
Traces to 1 document
1 reference not yet in our index
- 21 USC 360bbb–3
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources